… This categorization for our consensus document should not be considered as being directly
… referring to AAD in this consensus document, we also include the rate-controlling drugs. …

… the ‘Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document’
2 … gap between basal research and clinical practice determined a decrease in interest for the …

… , or in which data are insufficient to fully inform clinical decision making. … Consensus
Documents: to develop policy based on expert opinion in areas for which important clinical decisions …

… uptake of many effective antiarrhythmic therapies in these patients remains the slowest. This
European Heart Rhythm Association (EHRA) consensus document focuses on the biology …

… scribing physicians that many non-antiarrhythmic drugs can affect cardiac repolarisation, we
… list of QT-prolonging drugs that should be a starting point to maintain a ``consensus list'' to …

… our consensus document should not be considered as being directly similar to that used for
… This categorization for our consensus document should not be considered as being directly …

… available, to publish a joint consensus document on patient values and preferences for …
consensus recommendations for use in clinical practice. Hence this unique consensus document …

… antiarrhythmic drugs on the basis of the atrial electrical function as determined by age or
genetic predisposition36,45. Although a complex network of arrhythmogenic processes is likely …

… The objective of the consensus document is to provide clinical … Quinidine, a Class Ia
antiarrhythmic drug with I to and I Kr … arrhythmias in a clinical setting. Quinidine is currently being …

… Antiarrhythmic drugs for cardiac arrest in adults and children consensus on science and
treatment recommendations. Brussels, Belgium: International Liaison Committee on …